Moreover, in the clinical scenario of severe asthma exacerbated by infection/pneumonia that evolves to ALI, the targeting of Il-17 brings benefits not only in asthma, but may prevent or at least diminish the development of ALI. Here, IL17A is linked to acute respiratory distress syndrome.